The FDAs review of Modernas new mRNA f..

8 w

The FDA's review of Moderna's new mRNA flu vaccine concealed a statistically significant safety signal

Report: FDA’s Review of Moderna’s mRNA Flu Vaccine Concealed Statistically Significant Safety Signal – NaturalNews.com

www.naturalnews.com

Report: FDA’s Review of Moderna’s mRNA Flu Vaccine Concealed Statistically Significant Safety Signal – NaturalNews.com

The Food and Drug Administration (FDA) on Aug. 6 licensed Moderna’s mRNA influenza vaccine, mFLUSIVA, for adults 50 and older – marking the first time the agency has approved an mRNA shot for seasonal flu, according to a company statement cited

Like

Comment

Share